Type II 5-phosphatase Activators
Type II 5-phosphatase activators belong to a class of chemical compounds designed to modulate the activity of Type II 5-phosphatases, a group of enzymes that play a crucial role in cellular phosphoinositide metabolism and signal transduction. These enzymes specifically target the 5-phosphate group on inositol phospholipids, thereby regulating the levels of phosphatidylinositol 4,5-bisphosphate (PI(4,5)P2) in the cell. PI(4,5)P2 is a key player in numerous cellular processes, serving as a precursor for second messengers like inositol trisphosphate (IP3) and diacylglycerol (DAG), which are involved in intracellular signaling cascades.
Type II 5-phosphatase activators are engineered to interact with these enzymes and influence their enzymatic activity. By targeting Type II 5-phosphatases, these compounds may modulate the hydrolysis of PI(4,5)P2, thereby impacting downstream signaling pathways that rely on this lipid. This class of activators plays a vital role in investigating the complex web of intracellular signaling, as alterations in PI(4,5)P2 levels can affect processes such as membrane trafficking, cytoskeletal rearrangements, and ion channel regulation. Research focused on Type II 5-phosphatase activators provides insights into the intricate mechanisms of signal transduction and cellular responses to various extracellular cues, ultimately contributing to a deeper understanding of the molecular basis of cellular function and communication.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Insulin | 11061-68-0 | sc-29062 sc-29062A sc-29062B | 100 mg 1 g 10 g | $156.00 $1248.00 $12508.00 | 82 | |
Insulin activates PI3K/Akt signaling, which is intertwined with phosphoinositide signaling, potentially affecting INPP5B expression. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $67.00 $223.00 $425.00 | 97 | |
Wortmannin is a PI3K inhibitor. By inhibiting PI3K, it might influence the downstream signaling pathways and potentially the expression of INPP5B. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
LY294002 is another PI3K inhibitor. It might modulate phosphoinositide signaling and thus influence INPP5B expression. | ||||||
Ionomycin | 56092-82-1 | sc-3592 sc-3592A | 1 mg 5 mg | $78.00 $270.00 | 80 | |
Ionomycin increases intracellular calcium levels, affecting IP3-mediated calcium release, potentially influencing INPP5B expression. | ||||||
Staurosporine | 62996-74-1 | sc-3510 sc-3510A sc-3510B | 100 µg 1 mg 5 mg | $82.00 $153.00 $396.00 | 113 | |
Staurosporine is a broad-spectrum kinase inhibitor. It might influence various signaling pathways, potentially affecting INPP5B expression. | ||||||
Retinoic Acid, all trans | 302-79-4 | sc-200898 sc-200898A sc-200898B sc-200898C | 500 mg 5 g 10 g 100 g | $66.00 $325.00 $587.00 $1018.00 | 28 | |
Retinoic acid can influence cellular differentiation and might modulate phosphoinositide signaling, affecting INPP5B expression. | ||||||
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Forskolin raises cAMP levels, which might indirectly influence phosphoinositide signaling and INPP5B expression. | ||||||
8-Bromoadenosine 3′,5′-cyclic monophosphate | 23583-48-4 | sc-217493B sc-217493 sc-217493A sc-217493C sc-217493D | 25 mg 50 mg 100 mg 250 mg 500 mg | $108.00 $169.00 $295.00 $561.00 $835.00 | 2 | |
8-Br-cAMP is a cAMP analog that can influence cellular signaling, potentially affecting phosphoinositide dynamics and INPP5B expression. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
Rapamycin inhibits mTOR signaling, which intersects with phosphoinositide signaling, potentially influencing INPP5B expression. | ||||||